Survival prognostic analysis using the Kaplan‒Meier Plotter tool showed that low levels of CENPF expression predicted better overall survival (Fig. 1B, n = 1 879, log-rank P = 1.3e − 07) and recurrence-free survival (Fig. 1C, n = 4929, log-rank P < 1e − 15) in breast cancer. The gene discussed is CENPF; the disease is breast carcinoma.